BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8100992)

  • 1. Comparison of intradermal and subcutaneous hyperalgesic effects of inflammatory mediators in the rat.
    Khasar SG; Green PG; Levine JD
    Neurosci Lett; 1993 Apr; 153(2):215-8. PubMed ID: 8100992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of prostaglandin E1- and prostaglandin E2-induced hyperalgesia in the rat.
    Khasar SG; Ho T; Green PG; Levine JD
    Neuroscience; 1994 Sep; 62(2):345-50. PubMed ID: 7830882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal.
    Aley KO; Green PG; Levine JD
    J Neurosci; 1995 Dec; 15(12):8031-8. PubMed ID: 8613740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mu-opioid agonist enhancement of prostaglandin-induced hyperalgesia in the rat: a G-protein beta gamma subunit-mediated effect?
    Khasar SG; Wang JF; Taiwo YO; Heller PH; Green PG; Levine JD
    Neuroscience; 1995 Jul; 67(1):189-95. PubMed ID: 7477899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there more than one prostaglandin E receptor subtype mediating hyperalgesia in the rat hindpaw?
    Khasar SG; Ouseph AK; Chou B; Ho T; Green PG; Levine JD
    Neuroscience; 1995 Feb; 64(4):1161-5. PubMed ID: 7753383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of prostaglandin receptor subtype EP1 in prostaglandin E2-induced nociceptive transmission in the rat spinal dorsal horn.
    Nakayama Y; Omote K; Kawamata T; Namiki A
    Brain Res; 2004 Jun; 1010(1-2):62-8. PubMed ID: 15126118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DAMGO inhibits prostaglandin E2-induced potentiation of a TTX-resistant Na+ current in rat sensory neurons in vitro.
    Gold MS; Levine JD
    Neurosci Lett; 1996 Jul; 212(2):83-6. PubMed ID: 8832644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanical sensitization of cutaneous C-fiber nociceptors by prostaglandin E2 in the rat.
    Chen X; Tanner K; Levine JD
    Neurosci Lett; 1999 May; 267(2):105-8. PubMed ID: 10400223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated Mu-Opioid Exposure Induces a Novel Form of the Hyperalgesic Priming Model for Transition to Chronic Pain.
    Araldi D; Ferrari LF; Levine JD
    J Neurosci; 2015 Sep; 35(36):12502-17. PubMed ID: 26354917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of B1 and B2 receptors in bradykinin-induced rat paw oedema.
    Campos MM; Calixto JB
    Br J Pharmacol; 1995 Mar; 114(5):1005-13. PubMed ID: 7780633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the arachidonic acid metabolites mediating bradykinin and noradrenaline hyperalgesia.
    Taiwo YO; Levine JD
    Brain Res; 1988 Aug; 458(2):402-6. PubMed ID: 3061568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats.
    Ren K; Williams GM; Hylden JL; Ruda MA; Dubner R
    Eur J Pharmacol; 1992 Aug; 219(2):235-43. PubMed ID: 1358641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mu-opioid Receptor (MOR) Biased Agonists Induce Biphasic Dose-dependent Hyperalgesia and Analgesia, and Hyperalgesic Priming in the Rat.
    Araldi D; Ferrari LF; Levine JD
    Neuroscience; 2018 Dec; 394():60-71. PubMed ID: 30342200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary heat, but not mechanical, hyperalgesia induced by subcutaneous injection of bee venom in the conscious rat: effect of systemic MK-801, a non-competitive NMDA receptor antagonist.
    Chen HS; Chen J
    Eur J Pain; 2000; 4(4):389-401. PubMed ID: 11124011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.
    Sakurada S; Hayashi T; Yuhki M; Orito T; Zadina JE; Kastin AJ; Fujimura T; Murayama K; Sakurada C; Sakurada T; Narita M; Suzuki T; Tan-no K; Tseng LF
    Eur J Pharmacol; 2001 Sep; 427(3):203-10. PubMed ID: 11567650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid-Induced Hyperalgesic Priming in Single Nociceptors.
    Khomula EV; Araldi D; Bonet IJM; Levine JD
    J Neurosci; 2021 Jan; 41(1):31-46. PubMed ID: 33203743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased tumor necrosis factor-alpha and prostaglandin E2 concentrations in the cerebrospinal fluid of rats with inflammatory hyperalgesia: the effects of analgesic drugs.
    Bianchi M; Martucci C; Ferrario P; Franchi S; Sacerdote P
    Anesth Analg; 2007 Apr; 104(4):949-54. PubMed ID: 17377112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice.
    Minami T; Nishihara I; Uda R; Ito S; Hyodo M; Hayaishi O
    Br J Pharmacol; 1994 Jul; 112(3):735-40. PubMed ID: 7921597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOS inhibitor antagonism of PGE2-induced mechanical sensitization of cutaneous C-fiber nociceptors in the rat.
    Chen X; Levine JD
    J Neurophysiol; 1999 Mar; 81(3):963-6. PubMed ID: 10085324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Morphine Produces Dose-dependent Nociceptor-mediated Biphasic Changes in Nociceptive Threshold and Neuroplasticity.
    Ferrari LF; Araldi D; Bogen O; Green PG; Levine JD
    Neuroscience; 2019 Feb; 398():64-75. PubMed ID: 30529265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.